$ 233.18 <%= Resources.Global.txtUp %>
Updated 20/08/2019
Change % 0.82% Stock price increasing
Change 1.90 Stock price increasing
Volume 510,528
High $ 233.73
Low $ 0
Open $ 232.80
ISIN
Prev close $ 231.28
# of shares 184.45M
Market cap 43,009M USD
Intraday

Market closed
Biogen Inc
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  233.18 2.4% Stock price increasing 0.3% Stock price increasing -0.8% Stock price decreasing -28.3% Stock price decreasing -32.4% Stock price decreasing
Powered by TradingView

News about Biogen Inc

  • English
  • Regulatory news

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Abbott Laboratories 84.90 1.1% Stock price increasing -3.6% Stock price decreasing 11.3% Stock price increasing 11.5% Stock price increasing 29.3% Stock price increasing 17.4% Stock price increasing
 
Bristol-Myers Squibb Company 47.77 4.4% Stock price increasing 11.7% Stock price increasing 0.1% Stock price increasing -6.3% Stock price decreasing -21.1% Stock price decreasing -8.1% Stock price decreasing
 
Johnson & Johnson 131.53 0.8% Stock price increasing 2.2% Stock price increasing -5.2% Stock price decreasing -3.7% Stock price decreasing -2.3% Stock price decreasing 1.9% Stock price increasing
 
Pfizer Inc 34.87 1.1% Stock price increasing -18.6% Stock price decreasing -17.0% Stock price decreasing -18.8% Stock price decreasing -17.1% Stock price decreasing -20.1% Stock price decreasing
 
Amgen Inc 203.94 2.3% Stock price increasing 15.9% Stock price increasing 19.1% Stock price increasing 8.8% Stock price increasing 3.1% Stock price increasing 4.8% Stock price increasing
 
Novartis AG 90.12 1.7% Stock price increasing -4.2% Stock price decreasing 7.4% Stock price increasing -0.7% Stock price decreasing 7.7% Stock price increasing 5.0% Stock price increasing
 
GlaxoSmithKline PLC 40.69 1.8% Stock price increasing -1.1% Stock price decreasing 1.2% Stock price increasing 0.3% Stock price increasing -2.0% Stock price decreasing 6.5% Stock price increasing
 
UCB 68.86 1.7% Stock price increasing -7.6% Stock price decreasing -0.8% Stock price decreasing -11.6% Stock price decreasing -12.3% Stock price decreasing -3.4% Stock price decreasing
 
Roche Hldg Sp.Adr 1/8 31.07 2.1% Stock price increasing 4.4% Stock price increasing 5.7% Stock price increasing 3.4% Stock price increasing 18.5% Stock price increasing 20.3% Stock price increasing
 
Sanofi SA ADR 1/2/EO 2 39.00 4.3% Stock price increasing 6.0% Stock price increasing 4.3% Stock price increasing 7.1% Stock price increasing 5.4% Stock price increasing 6.6% Stock price increasing
 
Teva Pharmaceutical Industries.. 7.450 20.9% Stock price increasing -3.1% Stock price decreasing -35.4% Stock price decreasing -56.8% Stock price decreasing -70.4% Stock price decreasing -51.7% Stock price decreasing

Company profile

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Tysabri and Tecfidera. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis.

Peers

Instruments Last Change  
Abbott Labor.. 84.90 0.4% Stock price increasing
Bristol-Myer.. 47.77 0.3% Stock price increasing
Johnson & Jo.. 131.53 0.7% Stock price increasing
Pfizer Inc 34.87 0.8% Stock price increasing
Amgen Inc 203.94 0.4% Stock price increasing
68,5,43,58,42,51,29,25,34,2
Novartis AG 90.12 1.2% Stock price increasing
GlaxoSmithKl.. 40.69 1.1% Stock price increasing
UCB 68.86 1.4% Stock price increasing
Roche Hldg S.. 31.07 -0.7% Stock price decreasing
0,0,0,100,100,100,88,88,88,88
Sanofi SA AD.. 39.00 2.1% Stock price increasing
0,0,0,0,0,100,100,100,100,100
Teva Pharmac.. 7.450 6.3% Stock price increasing

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
22 August 2019 00:10:33
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190819.1 - EUROWEB2 - 2019-08-22 01:10:33 - 2019-08-22 00:10:33 - 1000 - Website: OKAY